Frontlight ResearchEarly access
CompletedNo phase
Hemogram Parameter Changes With Sepsis Filter
Key facts
- Who runs it
- Samsun University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 92 people enrolled
- Started
- 1 Jan 2024
- Ended
- 1 Feb 2024
- Type of study
- Observational
- Record updated
- 29 April 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Data of patients who were monitored in the Intensive Care between January 2020 and December 2022 and who were applied sepsis filters
Who cannot take part
- -Patients who underwent hemodiafiltration with sepsis filter but could not be followed for 72 hours (death, etc.)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Change in Hemogram-Derived Ratios With Sepsis Filters:A Retrospective Cohort Study in the Intensive Care Unit
- Record updated
- 29 April 2025